DR6 (NT) Blocking PeptideDR6 (NT) Blocking Peptide
Move your mouse over image or click to enlarge

DR6 (NT) Blocking Peptide

Death receptor-6 (DR6), a member of the death domain-containing TNFR superfamily, is highly expressed in lymphoid tissues and regulated upon lymphocyte activation. Targeted disruption of DR6 results in enhanced CD4(+) T cell proliferation and T helper 2 differentiation in vitro.1 DR6 contains an extracellular region and an intracellular region; the intracellular region harbors a death domain that is critical for transduction of apoptotic signals.2 DR6 interacts with death domain containing adapter molecule TRADD. Overexpression of DR6 induces apoptosis and activates NF-κB and JNK.
Cat# Size Price Qty Buy
D280-50ug 50ug £103.13

Additional Information

Property Value or Rating
Manufacturer Cat# D280
Product Size 50ug
Concentration 0.2 mg/ml
Formulation This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Manufacturer Leinco Technologies Inc
Alternate Names Blocking Peptide Death Receptor 6 TNFRSF21 DR6 Human DR6 DR6 (NT) Blocking Peptide
Storage Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Protein Death Receptor 6

Related Documents